The opening day of Techweek showcased innovative advancements in AI and biotechnology, emphasizing New Zealand's growing role in these sectors.
During the conference, BioOra's CEO John Robson shared a compelling case involving a young girl with acute leukemia, whose treatment journey highlighted the evolution of cancer therapies. Despite traditional chemotherapy failing, she was treated with CAR T-cell therapy, a groundbreaking approach that led to her remission. BioOra is now on the verge of commercializing a third-generation CAR T-cell therapy, Atla-cel, which promises fewer side effects and a higher success rate, aiming to position New Zealand as a leader in CAR-T treatments.
In another segment, Nicole Retter introduced her family management app, Pam, designed to streamline family organization. After overcoming initial challenges in development and funding, Pam has gained significant traction, amassing 32,000 downloads and achieving top rankings in app stores. The upcoming upgrade will incorporate AI features to enhance user experience.
Lastly, Arash Tayebi from Kara Technologies discussed his mission to improve accessibility for the deaf community through realistic digital sign language avatars. His technology aims to provide real-time translation of information and services, addressing the alarming statistic that 80% of deaf children lack access to education. Kara's partnership with the Singapore government and local transport authorities exemplifies the potential impact of this innovation.
These case studies illustrate how New Zealand is leveraging advanced technologies to address significant challenges in healthcare and accessibility, potentially transforming lives and setting new standards in the biotech sector.